首页> 外文OA文献 >Safety of Liposomal Cytarabine Prophylaxis in Pediatric Bone Marrow Transplant (BMT) Recipients with Acute Leukemia (AL) and Non Hodgkin Lymphoma (NHL) at High Risk of Cns Relapse

【2h】

Safety of Liposomal Cytarabine Prophylaxis in Pediatric Bone Marrow Transplant (BMT) Recipients with Acute Leukemia (AL) and Non Hodgkin Lymphoma (NHL) at High Risk of Cns Relapse

机译：Cns复发高风险的急性白血病（AL）和非霍奇金淋巴瘤（NHL）的小儿骨髓移植（BMT）接受者的脂质体阿糖胞苷预防的安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Hochberg J.; Duffy D.; Harrison L.; Morris E.; Cairo M.S.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma [J] . Hochberg J., Harrison L., Morris E., Bone marrow transplantation . 2016,第9期

机译：预防急性白血病和非霍奇金淋巴瘤的儿童，青少年和成人造血干细胞移植接受脂质体阿糖胞苷中枢神经系统预防的安全性
2. Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada. [J] . Schimmer AD, Jamal S, Messner H, Bone marrow transplantation . 2000,第8期

机译：非霍奇金淋巴瘤（NHL）的同种异体或自体骨髓移植（BMT）：一项省级策略的结果。加拿大安大略省BMT网络。
3. Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry [J] . Hazar Volkan, Kesik Vural, Karasuc Gulsun Tezcan, Leukemia and lymphoma . 2018,第1a2期

机译：预测接受造血干细胞移植的复发/难治性非霍奇金淋巴瘤的儿科患者存活的危险因素：土耳其小儿骨髓移植登记处的回顾性研究
4. Computationally derived cytological image markers for predicting risk of relapse in acute myeloid leukemia patients following bone marrow transplantation [C] . Sara ArabYarmohammadi, Zelin Zhang, Patrick Leo, Conference on Medical Imaging: Digital Pathology . 2020

机译：计算源自骨髓移植后急性髓性白血病患者复发风险的细胞学图像标志物
5. Evidence for heterogeneous genetic associations with acute lymphoblastic leukemia (ALL) by cytogenetics, age, and sex in high-risk patients treated with matched unrelated donor allogeneic blood or marrow transplant (URD-BMT) [D] . Clay, Alyssa I. 2016

机译：通过匹配的无关供体同种异体造血或骨髓移植（URD-BMT）治疗的高危患者中，通过细胞遗传学，年龄和性别进行的与急性淋巴细胞白血病（ALL）异质遗传关联的证据
6. Low Risk of Chronic Graft Versus Host Disease and Relapse Associated with T-Cell Depleted Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303 [O] . Steven M. Devine, Shelly Carter, Robert J Soiffer, -1

机译：慢性移植物的低风险抗宿主病和复发有关与T细胞耗尽外周血干对于急性髓性白血病中第一次缓解细胞移植的血液和骨髓移植的临床试验网络（BmT CTN）协议0303的结果
7. Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma [O] . J Hochberg, L Harrison, E Morris, 2016

机译：脂质体的脂质体溶血素CNS预防，儿童，青少年和年轻成人造血干细胞移植受者急性白血病和非霍奇金淋巴瘤

Safety of Liposomal Cytarabine Prophylaxis in Pediatric Bone Marrow Transplant (BMT) Recipients with Acute Leukemia (AL) and Non Hodgkin Lymphoma (NHL) at High Risk of Cns Relapse

著录项

相似文献

相关主题

期刊订阅